Candriam S.C.A. Takeda Pharmaceutical CO LTD Transaction History

Candriam S.C.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$13.12 - $15.03 $1,075 - $1,232	-82 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$13.54 - $15.35 $1,110 - $1,258	82 New	82 $1,000
Q4 2021 Feb 10, 2022	SELL	$13.17 - $16.4 $1,000 - $1,246	-76 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$16.3 - $17.26 $32 - $34	-2 Reduced 2.56%	76 $1,000
Q2 2021 Jul 20, 2021	BUY	$16.55 - $18.64 $1,290 - $1,453	78 New	78 $1,000

319

70.3M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.3B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.